More sponsors are seeking to launch and execute decentralized clinical trials (DCTs) than ever before. Industry watchers expect the market for DCTs to reach $10 billion by 2026, growing by 6.5% compound annual growth rate (CAGR) over the next five years. In 2020, COVID-19 catalyzed the already growing rate of DCT studies as many active studies without decentralized approaches were transitioned to support patient safety and trial continuity.
The result is that sponsors and CROs that were once slow to embrace the potential of DCTs, are now acutely aware of their advantages, such as higher patient engagement, optimized study enrollment, and patient retention. With all of this in mind, companies are now seeking to translate and expand upon the lessons they learned running DCTs during the pandemic – namely, applying DCT solutions globally.
Register for this webinar to hear Trinette Mitchell, Head, Clinical Trial Innovation, Takeda and John Reites, CEO, THREAD will share best practices and lessons learned over the past years in conducting global DCTs, including how to navigate complex regulatory landscapes. Register for this webinar to hear their novel insights.
Trinette Mitchell, Head, Clinical Trial Innovation, Takeda
Trinette Mitchell is a leader who transforms business process through the implementation of innovative technology. With a background in clinical data solutions and partnership management, Trinette is Takeda’s Head of Clinical Trial Innovation, where she leads a team focused on eClinical trial tools for decentralized trials.Message Presenter
John Reites, CEO, THREAD
Executive entrepreneur turned digital health entrepreneur, John’s career includes 18+ years of leading global drug development, clinical research and decentralized trials for life science organizations.
As President of THREAD, John leads the team’s efforts to change the way clinical research is conducted, focusing on decentralized approaches, enabling the use of the company’s one platform for conducting modern research studies and leading partnerships with the customers. After launching and growing THREAD, the company was acquired in 2019 by JLL Partners and Water Street with strategic investment for continued growth and focus on accelerating drug development for our customers.
Named one of the Top 100 Influencers in Digital Health, John also provides expertise and execution experience in digital health, clinical trials and decentralized, remote, virtual, community-based clinical research.
John enjoys being a keynote speaker at global industry events, a guest lecturer at Duke University on digital health/innovation/entrepreneurship and a published author featured in various conferences, journals, articles and media outlets.Message Presenter
Who Should Attend?
Professionals with responsibility for:
- Clinical Development
- Clinical Innovation
- Clinical Operations
- Clinical Research
- Clinical Project Managers
- Data Management
- Decentralized/Remote/Virtual Trials
- Digital Innovation/Strategy
- Medical Director
- Patient Experience
- Patient Engagement
- Patient Recruitment
- Trial Design
- Therapeutic Head/Lead
What You Will Learn
In this webinar, participants will learn:
- How to identify and plan the initial studies for DCT approaches to scale
- How to establish a global DCT platform and library-focused approach
- How to evaluate country-specific regulatory requirements and feature specific limitations
- How to develop a unique, efficient approach to global device provisioning
- How to assess DCT providers for optimal capabilities related to integrations, technical helpdesk, and multi-lingual support availability.
THREAD is a leading provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits. THREAD’s platform and supporting services are helping customers to shorten study launch timelines, reduce study budgets with Virtual Visits, and bring studies from the clinic to patients’ homes. THREAD provides key platform features such as eConsent, eCOA/ePRO, sensors, reminders, and telehealth Virtual Visits to support remote data capture, hybrid virtual studies, and fully decentralized studies in key therapeutic areas. In 2019, THREAD was acquired by strategic health care investors Water Street Healthcare Partners and JLL Partners. Visit us at https://www.threadresearch.com/